Nile Red structure
|
Common Name | Nile Red | ||
---|---|---|---|---|
CAS Number | 7385-67-3 | Molecular Weight | 318.369 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 484.7±45.0 °C at 760 mmHg | |
Molecular Formula | C20H18N2O2 | Melting Point | 203-205 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 246.9±28.7 °C |
Use of Nile RedNile Red is a strongly fluorescent stain in the presence of a hydrophobic environment for the detection of intracellular lipid droplets. |
Name | nile red dye |
---|---|
Synonym | More Synonyms |
Description | Nile Red is a strongly fluorescent stain in the presence of a hydrophobic environment for the detection of intracellular lipid droplets. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 484.7±45.0 °C at 760 mmHg |
Melting Point | 203-205 °C(lit.) |
Molecular Formula | C20H18N2O2 |
Molecular Weight | 318.369 |
Flash Point | 246.9±28.7 °C |
Exact Mass | 318.136841 |
PSA | 46.34000 |
LogP | 3.65 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.644 |
Stability | Stable. Incompatible with strong oxidizing agents. |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2933990090 |
~% Nile Red CAS#:7385-67-3 |
Literature: Ionescu, Andreea; Godbert, Nicolas; Crispini, Alessandra; Termine, Roberto; Golemme, Attilio; Ghedini, Mauro Journal of Materials Chemistry, 2012 , vol. 22, # 44 p. 23617 - 23626 |
~24% Nile Red CAS#:7385-67-3 |
Literature: Park, So-Yeon; Kubota, Yasuhiro; Funabiki, Kazumasa; Shiro, Motoo; Matsui, Masaki Tetrahedron Letters, 2009 , vol. 50, # 10 p. 1131 - 1135 |
~% Nile Red CAS#:7385-67-3 |
Literature: Justus Liebigs Annalen der Chemie, , vol. 289, p. 94 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Acoustic Cluster Therapy (ACT)--A novel concept for ultrasound mediated, targeted drug delivery.
Int. J. Pharm. 495 , 1019-27, (2015) A novel approach for ultrasound (US) mediated drug delivery - Acoustic Cluster Therapy (ACT) - is proposed, and basic characteristics of the ACT formulation are elucidated. The concept comprises admin... |
|
High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice.
PLoS ONE 10(3) , e0119784, (2015) High-fat diet (HFD) has been applied to a variety of inbred mouse strains to induce obesity and obesity related metabolic complications. In this study, we determined HFD induced development of metabol... |
|
microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells.
Cell Death Dis. 5 , e1499, (2014) The molecular mechanisms promoting lineage-specific commitment of human mesenchymal (skeletal or stromal) stem cells (hMSCs) into adipocytes (ADs) are not fully understood. Thus, we performed global m... |
5H-Benzo[a]phenoxazin-5-one, 9-(diethylamino)- |
Nile Red |
9-(Diethylamino)-5H-benzo[a]phenoxazin-5-one |
9-(Diethylamino)-5H-benzo(a)phenoxazin-5-one |
DCC impregnated tablets |
Nile Blue A Oxazone |
MFCD00011639 |
9-(Diethylamino)benzo(a)phenoxazin-5(5H)-one |
5H-Benzo(a)phenoxazin-5-one, 9-(diethylamino)- |
9-(diethylamino)benzo[a]phenoxazin-5-one |
EINECS 230-966-0 |